Eble JN, Tavassoli FA, Devilee P (2003) Pathology and genetics of tumours of the breast and female genital organs. Iarc
McDivitt RW, Stewart FW (1966) Breast carcinoma in children. JAMA 195:388–390
Article CAS PubMed Google Scholar
Tavassoli FA, Norris HJ (1980) Secretory carcinoma of the breast. Cancer 45:2404–2413. https://doi.org/10.1002/1097-0142(19800501)45:9%3c2404::aid-cncr2820450928%3e3.0.co;2-8
Article CAS PubMed Google Scholar
de Bree E et al (2002) Secretory carcinoma of the male breast. Ann Surg Oncol 9:663–667. https://doi.org/10.1007/bf02574482
Aktepe F, Sarsenov D, Özmen V (2016) Secretory carcinoma of the breast. J Breast Health 12:174–176. https://doi.org/10.5152/bs.2016.3249
Article PubMed PubMed Central Google Scholar
Jacob JD et al (2016) Rare breast cancer: 246 invasive secretory carcinomas from the National Cancer Data Base. J Surg Oncol 113:721–725. https://doi.org/10.1002/jso.24241
Article CAS PubMed Google Scholar
Tognon C et al (2002) Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2:367–376. https://doi.org/10.1016/s1535-6108(02)00180-0
Article CAS PubMed Google Scholar
Laé M et al (2009) Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum. Mod Pathol 22:291–298. https://doi.org/10.1038/modpathol.2008.184
Article CAS PubMed Google Scholar
Del Castillo M et al (2015) Secretory breast carcinoma: a histopathologic and genomic spectrum characterized by a joint specific ETV6-NTRK3 gene fusion. Am J Surg Pathol 39:1458–1467. https://doi.org/10.1097/pas.0000000000000487
Bishop JA et al (2017) Secretory carcinoma of the skin harboring ETV6 gene fusions: a cutaneous analogue to secretory carcinomas of the breast and salivary glands. Am J Surg Pathol 41:62–66. https://doi.org/10.1097/pas.0000000000000734
Ozguroglu M, Tascilar K, Ilvan S, Soybir G, Celik V (2005) Secretory carcinoma of the breast: case report and review of the literature. Oncology 68:263–268. https://doi.org/10.1159/000086782
Horowitz DP, Sharma CS, Connolly E, Gidea-Addeo D, Deutsch I (2012) Secretory carcinoma of the breast: results from the survival, epidemiology and end results database. Breast 21:350–353. https://doi.org/10.1016/j.breast.2012.02.013
Tokunaga M et al (1985) Juvenile secretory carcinoma and juvenile papillomatosis. Jpn J Clin Oncol 15:457–465
Nguyen GK, Neifer R (1987) Aspiration biopsy cytology of secretory carcinoma of the breast. Diagn Cytopathol 3:234–237. https://doi.org/10.1002/dc.2840030312
Article CAS PubMed Google Scholar
Krausz T, Jenkins D, Grontoft O, Pollock DJ, Azzopardi JG (1989) Secretory carcinoma of the breast in adults: emphasis on late recurrence and metastasis. Histopathology 14:25–36. https://doi.org/10.1111/j.1365-2559.1989.tb02111.x
Article CAS PubMed Google Scholar
Krohn M, Trams G, Brandt G (1989) Secretory breast cancer. A special morphologic entity, especially in children and young females. Geburtshilfe Frauenheilkd 49:299–301. https://doi.org/10.1055/s-2008-1035759
Article CAS PubMed Google Scholar
Herz H, Cooke B, Goldstein D (2000) Metastatic secretory breast cancer: non-responsiveness to chemotherapy: case report and review of the literature. Ann Oncol 11:1343–1347. https://doi.org/10.1023/a:1008387800525
Article CAS PubMed Google Scholar
Woto-Gaye G, Kasse AA, Dieye Y, Toure P, Demba Ndiaye P (2004) Secretory breast carcinoma in a man: a case report with rapid evolution unfavorable. Ann Pathol 24(432–435):2004. https://doi.org/10.1016/s0242-6498(04)93999-5
Arce C et al (2005) Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: case report and review of the literature. World J Surg Oncol 3:35. https://doi.org/10.1186/1477-7819-3-35
Article CAS PubMed PubMed Central Google Scholar
Anderson P, Albarracin CT, Resetkova E (2006) A large, fungating breast mass: secretory carcinoma with apocrine differentiation. Arch Pathol Lab Med 130:50–52. https://doi.org/10.5858/2006-130-e50-ALFBM
Wong M et al (2012) ETV6 disruption does not predict indolent clinical behavior in secretory breast carcinoma. Breast J 18:604–606. https://doi.org/10.1111/tbj.12041
Article CAS PubMed Google Scholar
Lian J et al (2017) Secretory breast carcinoma with liver metastatic: report of a case. Zhonghua Bing Li Xue Za Zhi 46:124–125. https://doi.org/10.3760/cma.j.issn.0529-5807.2017.02.017
Article CAS PubMed Google Scholar
Hoda RS et al (2019) Secretory carcinoma of the breast: clinicopathologic profile of 14 cases emphasising distant metastatic potential. Histopathology 75:213–224. https://doi.org/10.1111/his.13879
Article PubMed PubMed Central Google Scholar
Tang H et al (2021) Secretory carcinoma of the breast with multiple distant metastases in the brain and unfavorable prognosis: a case report and literature review. Diagn Pathol 16:56. https://doi.org/10.1186/s13000-021-01115-1
Article PubMed PubMed Central Google Scholar
Lian J et al (2021) Secretory breast carcinoma in a female adult with liver metastsis: a case report and literature review. Diagn Pathol 16:89. https://doi.org/10.1186/s13000-021-01156-6
Article CAS PubMed PubMed Central Google Scholar
Hammond ME et al (2010) American society of clinical oncology/college of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28:2784–2795. https://doi.org/10.1200/jco.2009.25.6529
Article PubMed PubMed Central Google Scholar
Wolff AC et al (2018) Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. J Clin Oncol 36:2105–2122. https://doi.org/10.1200/jco.2018.77.8738
Article CAS PubMed Google Scholar
Solomon JP, Benayed R, Hechtman JF, Ladanyi M (2019) Identifying patients with NTRK fusion cancer. Ann Oncol 30:816–822. https://doi.org/10.1093/annonc/mdz384
Connor A, Perez-Ordoñez B, Shago M, Skálová A, Weinreb I (2012) Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity. Am J Surg Pathol 36:27–34. https://doi.org/10.1097/PAS.0b013e318231542a
Dehejia RH, Wahba S (2002) Propensity Score-Matching Methods for Nonexperimental Causal Studies. Rev Econ Stat 84:151–161. https://doi.org/10.1162/003465302317331982
Wang J (2021) To use or not to use propensity score matching? Pharm Stat 20:15–24. https://doi.org/10.1002/pst.2051
Badhiwala JH, Karmur BS, Wilson JR (2021) Propensity score matching: a powerful tool for analyzing observational nonrandomized data. Clin Spine Surg 34:22–24. https://doi.org/10.1097/bsd.0000000000001055
Austin PC (2011) Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 10:150–161
Ascierto PA, Long GV (2016) Progression-free survival landmark analysis: a critical endpoint in melanoma clinical trials. Lancet Oncol 17:1037–1039. https://doi.org/10.1016/s1470-2045(16)30017-1
De Bruyne B et al (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367:991–1001. https://doi.org/10.1056/NEJMoa1205361
Article CAS PubMed Google Scholar
Fu J et al (2021) Distinct impacts of pre-operative antiviral treatment on post-operative outcomes of HBV-related hepatocellular carcinoma: a landmark analysis. J Cancer 12:170–180. https://doi.org/10.7150/jca.47125
Article CAS PubMed PubMed Central Google Scholar
Ayre G et al (2019) Secretory carcinoma of the major salivary gland: Provincial population-based analysis of clinical behavior and outcomes. Head Neck 41:1227–1236. https://doi.org/10.1002/hed.25536
Comments (0)